Cargando…

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives

Phosphodiesterase 5 (PDE5) inhibitors presented themselves as important players in the nitric oxide/cGMP pathway, thus exerting a profound impact on various physiological and pathological processes. Beyond their well-known efficacy in treating male erectile dysfunction (ED) and pulmonary arterial hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	ElHady, Ahmed K., El-Gamil, Dalia S., Abdel-Halim, Mohammad, Abadi, Ashraf H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536424/ https://www.ncbi.nlm.nih.gov/pubmed/37765073 http://dx.doi.org/10.3390/ph16091266

Ejemplares similares

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency
por: ElHady, Ahmed K., et al.
Publicado: (2021)

Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors
por: Abadi, Ashraf H., et al.
Publicado: (2011)

Structure-Based Design of Novel Tetrahydro-Beta-Carboline Derivatives with a Hydrophilic Side Chain as Potential Phosphodiesterase Inhibitors
por: Elhady, Ahmed K., et al.
Publicado: (2015)

Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer
por: Ammar, Lina, et al.
Publicado: (2023)

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives
por: Konstantinopoulos, Angelis, et al.
Publicado: (2007)

Unveiling the Pharmacological and Nanotechnological Facets of Daidzein: Present State-of-the-Art and Future Perspectives
por: Singh, Sukhbir, et al.
Publicado: (2023)

Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia
por: Alshahrani, Saad, et al.
Publicado: (2016)

Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
por: Mokra, Daniela, et al.
Publicado: (2021)

COVID-19 caseness: An epidemiologic perspective
por: El-Gilany, Abdel-Hady
Publicado: (2021)

A Systematic Survey on Sensor Failure Detection and Fault-Tolerance in Ambient Assisted Living
por: ElHady, Nancy E., et al.
Publicado: (2018)

Evolution and expression of the phosphodiesterase 6 genes unveils vertebrate novelty to control photosensitivity
por: Lagman, David, et al.
Publicado: (2016)

Evaluation of genetic diversity in wild populations of Peganum harmala L., a medicinal plant
por: EL-Bakatoushi, Ranya, et al.
Publicado: (2018)

Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist
por: Ribaudo, Giovanni, et al.
Publicado: (2020)

Torsional Mode Phacoemulsification: Effective, Safe Cataract Surgery Technique of the Future
por: El-Moatassem Kotb, Ahmed M., et al.
Publicado: (2010)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Effect of phosphodiesterase inhibitors in the bladder
por: Chughtai, Bilal, et al.
Publicado: (2015)

Editorial: Advances and Perspective in bio-implants for commercialization
por: Sidhu, Sarabjeet Singh, et al.
Publicado: (2023)

Advances, Perspectives and Potential Engineering Strategies of Light-Gated Phosphodiesterases for Optogenetic Applications
por: Tian, Yuehui, et al.
Publicado: (2020)

Design, synthesis and biological evaluation of new 2-aminothiazole scaffolds as phosphodiesterase type 5 regulators and COX-1/COX-2 inhibitors
por: Hussein, Abdel Haleem M., et al.
Publicado: (2020)

Effect of Phosphodiesterase Inhibitor on Diabetic Nephropathy
por: Kang, Shin-Wook
Publicado: (2012)

Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
por: Tiwari, Amit K., et al.
Publicado: (2013)

Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis
por: Ahidjo, Bintou Ahmadou, et al.
Publicado: (2016)

New Avenues for Phosphodiesterase Inhibitors in Asthma
por: Matera, Maria Gabriella, et al.
Publicado: (2021)

Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties
por: Amin, Kamelia M., et al.
Publicado: (2022)

Unveiling the Human Gastrointestinal Tract Microbiome: The Past, Present, and Future of Metagenomics
por: Athanasopoulou, Konstantina, et al.
Publicado: (2023)

Phosphodiesterase-III Inhibitors Amrinone and Milrinone on Epilepsy and Cardiovascular Activities
por: Asif, Mohammad
Publicado: (2012)

Sensor Failure Detection in Ambient Assisted Living Using Association Rule Mining
por: ElHady, Nancy E., et al.
Publicado: (2020)

PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives
por: Fuso, Paola, et al.
Publicado: (2022)

Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors
por: Lee, Sang-Yong, et al.
Publicado: (2017)

Respiratory Care Profession in Yemen: Past, Present, and Future
por: Hamilah, Saleem N, et al.
Publicado: (2021)

Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
por: Gooderham, Melinda, et al.
Publicado: (2015)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
por: Li, Heng, et al.
Publicado: (2018)

Phosphodiesterase-5 inhibitors for colon cancer chemoprevention
por: Islam, Bianca N., et al.
Publicado: (2018)

Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
por: Hutchings, David Charles, et al.
Publicado: (2018)

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs
por: Abassi, Zaid, et al.
Publicado: (2015)

Methylxanthines and Phosphodiesterase Inhibitors in the Treatment of Airways Disease
por: Semple, S J G
Publicado: (1995)

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
por: Janosova, Viera, et al.
Publicado: (2020)

Effect and Mechanism of Phosphodiesterase Inhibitors on Trabecular Outflow
por: Kim, Jae Woo, et al.
Publicado: (2019)

Long-term effectiveness and predictors of success of low-intensity shockwave therapy in phosphodiesterase type 5 inhibitors non-responders
por: Musa, Zubairu S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cdvs4vbn90allpisq8je5v60tp